Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
Open Access
- 1 January 2002
- journal article
- guideline
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 9 (1), 1-27
- https://doi.org/10.5551/jat.9.1
Abstract
This paper described the Guideline for Diagnosis and Management of Hyperlipidemias for Prevention of Atherosclerosis proposed by The Japan Atherosclerosis Society (JAS) Guideline Investigating Committee (1, 995-2, 000) under the auspices of the JAS Board of Directors. 1) The guideline defines the diagnostic criteria for serum total cholesterol (Table 1), LDL-cholesterol (Table 1), triglycerides (Table 4) and HDL-cholesterol (Table 7). It also indicates the desirable range (Table 1), the initiation levels of management (Table 2) and the target levels of treatment (Table 2) for total and LDL-cholesterol. 2) Though both total and LDL-cholesterol are shown as atherogenic parameter in the guideline, the use of LDL-cholesterol, rather than total cholesterol, is encouraged in daily medical practice and lipid-related studies, because LDL-cholesterol is more closely related to atherosclerosis. 3) Elevated triglycerides and low HDL-cholesterol are included in the risk factors, since no sufficient data have been accumulated to formulate the guideline for these two lipid disorders. 4) Emphasis is laid on evaluation of risk factors of each subject before starting any kind of treatment (Table 2). 5) This guideline is applied solely for adults (age 20-64). Lipid abnormalities in children or the youth under age 19, and the elderly with an age over 65 have to be evaluated by their own standard. 6) This part of the guideline gives only the diagnostic aspects of hyperlipidemias. The part of management and treatment will follow in the second section of the guideline that will be published in future.Keywords
This publication has 97 references indexed in Scilit:
- Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.Stroke, 1992
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionThe New England Journal of Medicine, 1985
- Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke.Stroke, 1982
- Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack.Stroke, 1981
- Epidemiology as a Guide to Clinical DecisionsThe New England Journal of Medicine, 1980
- Atherogenesis: a postprandial phenomenon.Circulation, 1979
- Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling projectJournal of Chronic Diseases, 1978
- Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Coronary heart disease risk factors in Japan and HawaiiThe American Journal of Cardiology, 1977
- Role of Lipids in the Development of Brain Infarction: The Framingham StudyStroke, 1974